Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FL058 vs piperacillin + tazobactam in adult complicated urinary tract infection
CTR20212255Phase 2Completed
- Sponsor
- Qilu Pharmaceutical
- Start
- Sep 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pralubactam in complicated urinary tract infection (cUTI), acute pyelonephritis, sponsored by Qilu Pharmaceutical. Started Sep 2021; status: completed.
02
Drugs
pralubactam
03
Conditions
complicated urinary tract infection (cUTI)acute pyelonephritis
Beyond the preview
Go deeper on CTR20212255.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20212255.